TREMELIMUMAB

TREMELIMUMAB was reported 4428 times

TREMELIMUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARDIOHEPATIC SYNDROME 1 0.3333
1 OESOPHAGOMEDIASTINAL FISTULA 6 0.3000
2 MICROCOCCAL SEPSIS 4 0.2000
3 LIVER CARCINOMA RUPTURED 33 0.1310
4 PROTEIN INDUCED BY VITAMIN K ABSENCE OR ANTAGONIST II INCREASED 6 0.0822
5 IMMUNOTOXICITY 9 0.0789
6 CHONDROSARCOMA METASTATIC 2 0.0741
7 BILIARY TRACT INFECTION 36 0.0579
8 TUMOUR HYPERPROGRESSION 13 0.0524
9 IMMUNE-MEDIATED HEPATIC DISORDER 97 0.0497
10 OLFACTORY DYSFUNCTION 2 0.0476
11 LUNG SQUAMOUS CELL CARCINOMA RECURRENT 2 0.0465
12 IMMUNE-MEDIATED ENTEROCOLITIS 159 0.0432
13 IMMUNE-MEDIATED DERMATITIS 43 0.0427
14 BLOOD BETA-D-GLUCAN POSITIVE 1 0.0385
15 GASTROENTERITIS AEROMONAS 1 0.0370
16 MYOCARDITIS-MYOSITIS-MYASTHENIA GRAVIS OVERLAP SYNDROME 8 0.0351
17 CHOLANGITIS INFECTIVE 9 0.0338
18 IMMUNE-MEDIATED HEPATITIS 69 0.0338
19 AUTOIMMUNE NEPHRITIS 7 0.0318
20 IMMUNE-MEDIATED PANCREATITIS 12 0.0315
21 EXPOSURE TO BODY FLUID 1 0.0312
22 AEROMONAS TEST POSITIVE 1 0.0312
23 SUSPECTED DRUG-INDUCED LIVER INJURY 6 0.0300
24 ENDOCRINE TOXICITY 3 0.0294
25 IMMUNE-MEDIATED HYPOPHYSITIS 13 0.0288
26 IMMUNE-MEDIATED CYTOPENIA 2 0.0286
27 PERICARDITIS MALIGNANT 3 0.0280
28 IMMUNE-MEDIATED MYOCARDITIS 45 0.0278
29 IMMUNE-MEDIATED OESOPHAGITIS 2 0.0278
30 ENTEROCOLITIS INFECTIOUS 25 0.0271
31 HEPATIC CYST RUPTURED 1 0.0270
32 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 20 0.0251
33 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 22 0.0251
34 ALPHA 1 FOETOPROTEIN DECREASED 1 0.0250
35 NON-SMALL CELL LUNG CANCER RECURRENT 7 0.0247
36 CANDIDA ENDOPHTHALMITIS 3 0.0246
37 CAMPYLOBACTER COLITIS 2 0.0233
38 IMMUNE-MEDIATED ENCEPHALOPATHY 2 0.0225
39 IMMUNE-MEDIATED NEPHRITIS 10 0.0213
40 HYPOPITUITARISM 35 0.0201
41 TUMOUR RUPTURE 11 0.0196
42 IMMUNE-MEDIATED CHOLANGITIS 7 0.0195
43 IMMUNE-MEDIATED RENAL DISORDER 8 0.0193
44 BILIARY CANCER METASTATIC 1 0.0192
45 ADRENALITIS 2 0.0187
46 IMMUNE-MEDIATED MYASTHENIA GRAVIS 6 0.0185
47 FULMINANT TYPE 1 DIABETES MELLITUS 19 0.0184
48 LYMPHOCYTIC HYPOPHYSITIS 5 0.0181
49 KL-6 INCREASED 4 0.0177
50 ALPHA 1 FOETOPROTEIN INCREASED 12 0.0169
51 CYTOMEGALOVIRUS GASTROINTESTINAL ULCER 1 0.0164
52 SPONTANEOUS BACTERIAL PERITONITIS 4 0.0164
53 IMMUNE-MEDIATED ADVERSE REACTION 24 0.0156
54 MORAXELLA INFECTION 4 0.0146
55 BACILLUS INFECTION 9 0.0142
56 AUTOIMMUNE PANCREATITIS 7 0.0138
57 HEPATIC RUPTURE 3 0.0134
58 AUTOIMMUNE DERMATITIS 2 0.0132
59 IMMUNE-MEDIATED ENCEPHALITIS 7 0.0132
60 IMMUNE-MEDIATED ARTHRITIS 5 0.0131
61 TRACHEAL FISTULA 2 0.0130
62 IMMUNE-MEDIATED NEUROPATHY 2 0.0129
63 VARICOSE VEIN RUPTURED 4 0.0125
64 RENAL VASCULITIS 4 0.0125
65 BLOOD CORTICOTROPHIN DECREASED 6 0.0123
66 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 15 0.0120
67 EUTHYROID SICK SYNDROME 1 0.0118
68 BILE DUCT STENOSIS 14 0.0117
69 HYPOPHYSITIS 23 0.0114
70 AUTOIMMUNE ENTEROPATHY 1 0.0114
71 GALLBLADDER OBSTRUCTION 3 0.0113
72 IMMUNE-MEDIATED LUNG DISEASE 20 0.0110
73 ENTEROCOLITIS 62 0.0107
74 HAEMORRHAGIC ASCITES 3 0.0105
75 SICCA SYNDROME 2 0.0104
76 HYPOTHALAMO-PITUITARY DISORDER 15 0.0103
77 DISSEMINATED MUCORMYCOSIS 4 0.0102
78 ERYTHEMA MIGRANS 1 0.0100
79 AXONAL AND DEMYELINATING POLYNEUROPATHY 1 0.0098
80 IMMUNE-MEDIATED HYPOTHYROIDISM 11 0.0098
81 AORTIC INJURY 1 0.0095
82 IMMUNE-MEDIATED MYOSITIS 26 0.0094
83 AUTOIMMUNE COLITIS 6 0.0093
84 CHOLANGITIS ACUTE 7 0.0093
85 ACUTE ON CHRONIC LIVER FAILURE 2 0.0093
86 INTERLEUKIN LEVEL INCREASED 5 0.0091
87 CYTOKINE STORM 6 0.0088
88 MYOCARDITIS 100 0.0087
89 CYTOKINE RELEASE SYNDROME 175 0.0087
90 ENANTHEMA 5 0.0087
91 IMMUNE-MEDIATED THYROIDITIS 4 0.0081
92 HEPATIC INFECTION 10 0.0078
93 ENDOCRINE DISORDER 10 0.0078
94 GASTRODUODENAL HAEMORRHAGE 1 0.0078
95 ADRENAL INSUFFICIENCY 93 0.0077
96 THYROIDITIS 23 0.0077
97 PANCREATIC ENZYMES INCREASED 11 0.0075
98 DECOMPENSATED HYPOTHYROIDISM 1 0.0074
99 BLEEDING VARICOSE VEIN 4 0.0074
100 TUMOUR ASSOCIATED FEVER 3 0.0073
101 ENCEPHALOMYELITIS 2 0.0073
102 ADRENAL DISORDER 14 0.0073
103 ENTEROCOLITIS BACTERIAL 2 0.0072
104 LIMBIC ENCEPHALITIS 2 0.0072
105 HAEMOBILIA 3 0.0072
106 CRANIAL NERVE PALSIES MULTIPLE 1 0.0071
107 GLUCOCORTICOID DEFICIENCY 3 0.0071
108 COLLATERAL CIRCULATION 1 0.0069
109 METASTASES TO PLEURA 7 0.0067
110 DUODENAL OBSTRUCTION 2 0.0067
111 CAUDA EQUINA SYNDROME 5 0.0065
112 MYASTHENIC SYNDROME 5 0.0065
113 AUTOIMMUNE MYOSITIS 3 0.0064
114 COLITIS EROSIVE 1 0.0063
115 ACTIVITIES OF DAILY LIVING DECREASED 4 0.0063
116 CORTISOL DECREASED 7 0.0061
117 THROMBOPHLEBITIS MIGRANS 2 0.0059
118 MYOSITIS 52 0.0058
119 ADRENOCORTICAL INSUFFICIENCY ACUTE 11 0.0056
120 DIABETIC KETOACIDOTIC HYPERGLYCAEMIC COMA 1 0.0055
121 PANCREATIC ENLARGEMENT 2 0.0054
122 GRANULOMATOUS LYMPHADENITIS 1 0.0053
123 HYPOPARATHYROIDISM 4 0.0052
124 CYTOMEGALOVIRUS ENTEROCOLITIS 4 0.0052
125 COLITIS 194 0.0051
126 MYASTHENIA GRAVIS 40 0.0049
127 PERIPHERAL CIRCULATORY FAILURE 2 0.0049
128 LICHENOID KERATOSIS 11 0.0048
129 EOSINOPHILIC CELLULITIS 1 0.0047
130 EMPHYSEMATOUS CYSTITIS 1 0.0047
131 CHOLANGITIS 29 0.0047
132 HAEMOPHILIA 1 0.0047
133 PULMONARY TOXICITY 33 0.0047
134 EMPTY SELLA SYNDROME 1 0.0046
135 AUTOIMMUNE MYOCARDITIS 1 0.0046
136 FACIAL NERVE DISORDER 2 0.0045
137 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 5 0.0045
138 ABSCESS NECK 3 0.0044
139 METASTASES TO ADRENALS 4 0.0043
140 LIVER ABSCESS 14 0.0043
141 PRERENAL FAILURE 6 0.0043
142 AUTOIMMUNE HYPOTHYROIDISM 1 0.0042
143 HEPATORENAL SYNDROME 7 0.0041
144 GRANULOMATOSIS WITH POLYANGIITIS 5 0.0041
145 APPENDICEAL ABSCESS 1 0.0041
146 MUCOSAL DISORDER 4 0.0040
147 SECONDARY ADRENOCORTICAL INSUFFICIENCY 6 0.0040
148 NON-SMALL CELL LUNG CANCER 19 0.0040
149 CYTOMEGALOVIRUS GASTRITIS 1 0.0040
150 CREATINE KINASE INCREASED 3 0.0039
151 NEPHRITIS 13 0.0039
152 TUMOUR HAEMORRHAGE 11 0.0039
153 URINARY TRACT OBSTRUCTION 9 0.0038
154 URTICARIAL VASCULITIS 2 0.0038
155 PNEUMONITIS 103 0.0038
156 HAEMOPERITONEUM 3 0.0037
157 HEPATITIS VIRAL 3 0.0037
158 IMMUNE THROMBOCYTOPENIA 17 0.0037
159 TUMOUR PSEUDOPROGRESSION 4 0.0037
160 SUPERFICIAL VEIN THROMBOSIS 3 0.0036
161 HEPATIC CANCER RECURRENT 1 0.0035
162 BLOOD CORTICOTROPHIN INCREASED 1 0.0035
163 GENERALISED PUSTULAR PSORIASIS 1 0.0034
164 AUTOIMMUNE HEPATITIS 24 0.0034
165 HEPATIC ENCEPHALOPATHY 32 0.0034
166 POLYARTERITIS NODOSA 2 0.0034
167 HEPATORENAL FAILURE 2 0.0033
168 ENTEROBACTER BACTERAEMIA 1 0.0033
169 NEURODEGENERATIVE DISORDER 2 0.0032
170 OESOPHAGEAL VARICES HAEMORRHAGE 7 0.0032
171 BRONCHIAL HAEMORRHAGE 1 0.0032
172 HEPATOBILIARY DISEASE 2 0.0032
173 ENTERITIS 20 0.0031
174 OBSTRUCTION GASTRIC 4 0.0031
175 ANOREXIA NERVOSA 1 0.0031
176 BILIARY OBSTRUCTION 4 0.0031
177 ENCEPHALITIS AUTOIMMUNE 4 0.0030
178 CENTRAL HYPOTHYROIDISM 1 0.0030
179 LIVER DISORDER 133 0.0030
180 AMYLASE INCREASED 11 0.0030
181 STEROID WITHDRAWAL SYNDROME 3 0.0029
182 STASIS DERMATITIS 2 0.0029
183 CUTANEOUS SYMPTOM 2 0.0029
184 GAS GANGRENE 1 0.0029
185 METASTASES TO SKIN 3 0.0029
186 EPISCLERITIS 2 0.0029
187 HEPATOCELLULAR CARCINOMA 22 0.0029
188 HEPATITIS 74 0.0029
189 EOSINOPHILIC FASCIITIS 1 0.0029
190 LYMPHANGIOSIS CARCINOMATOSA 3 0.0029
191 MALIGNANT NEOPLASM PROGRESSION 294 0.0029
192 PERIPHERAL MOTOR NEUROPATHY 4 0.0029
193 CULTURE URINE POSITIVE 4 0.0028
194 TUMOUR NECROSIS 3 0.0028
195 POLYMYOSITIS 5 0.0028
196 CYSTITIS ESCHERICHIA 1 0.0028
197 RADIATION PNEUMONITIS 6 0.0028
198 STREPTOCOCCAL BACTERAEMIA 3 0.0028
199 RADICULOPATHY 7 0.0027
200 THYROTOXIC CRISIS 3 0.0026
201 SQUAMOUS CELL CARCINOMA OF LUNG 2 0.0026
202 DUODENITIS 8 0.0026
203 PULMONARY ARTERY THROMBOSIS 2 0.0026
204 HEPATIC FUNCTION ABNORMAL 97 0.0026
205 MYELITIS 4 0.0026
206 VITILIGO 6 0.0026
207 ASYMPTOMATIC COVID-19 1 0.0025
208 DIARRHOEA INFECTIOUS 2 0.0025
209 GROWTH HORMONE DEFICIENCY 1 0.0025
210 POLYMYALGIA RHEUMATICA 8 0.0025
211 ESCHERICHIA TEST POSITIVE 3 0.0025
212 EMBOLISM 20 0.0024
213 MALIGNANT PLEURAL EFFUSION 4 0.0024
214 BLOOD BILIRUBIN ABNORMAL 3 0.0023
215 HEPATIC CANCER METASTATIC 2 0.0023
216 TYPE 1 DIABETES MELLITUS 14 0.0023
217 ENCEPHALITIS 16 0.0023
218 ENDOCRINE OPHTHALMOPATHY 2 0.0023
219 NON-SMALL CELL LUNG CANCER METASTATIC 2 0.0023
220 LUNG OPACITY 6 0.0023
221 GUILLAIN-BARRE SYNDROME 11 0.0023
222 CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS 1 0.0022
223 SIALOADENITIS 3 0.0022
224 EPIDERMOLYSIS 1 0.0022
225 DRUG-INDUCED LIVER INJURY 68 0.0022
226 PORTAL VEIN THROMBOSIS 7 0.0022
227 GASTROINTESTINAL PERFORATION 9 0.0022
228 GALLBLADDER RUPTURE 1 0.0022
229 HERPES SIMPLEX ENCEPHALITIS 1 0.0022
230 LICHEN PLANUS 5 0.0022
231 EATING DISORDER SYMPTOM 1 0.0022
232 SMALL INTESTINAL PERFORATION 4 0.0021
233 ECZEMA ASTEATOTIC 1 0.0021
234 CRANIAL NERVE PARALYSIS 1 0.0021
235 LIPASE INCREASED 16 0.0021
236 BLAST CELLS PRESENT 1 0.0021
237 HEPATIC MASS 4 0.0021
238 CARCINOEMBRYONIC ANTIGEN INCREASED 4 0.0021
239 DUODENAL STENOSIS 1 0.0021
240 EXOSTOSIS OF JAW 1 0.0020
241 BLADDER MASS 1 0.0020
242 LARGE INTESTINE PERFORATION 14 0.0020
243 METASTASES TO LUNG 23 0.0020
244 JAUNDICE CHOLESTATIC 7 0.0020
245 AUTONOMIC NEUROPATHY 2 0.0020
246 CENTRAL NERVOUS SYSTEM VASCULITIS 1 0.0020
247 INTERSTITIAL LUNG DISEASE 92 0.0019
248 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 14 0.0019
249 GALLBLADDER ENLARGEMENT 2 0.0019
250 ENZYME ABNORMALITY 1 0.0019
251 HYPOTHYROIDISM 59 0.0018
252 HYPERAMYLASAEMIA 1 0.0018
253 PNEUMONIA STREPTOCOCCAL 2 0.0018
254 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 2 0.0018
255 VANISHING BILE DUCT SYNDROME 2 0.0018
256 ENTERITIS INFECTIOUS 3 0.0018
257 RADIATION SKIN INJURY 2 0.0017
258 PAROTITIS 2 0.0017
259 RECTAL ULCER 2 0.0017
260 CAMPYLOBACTER GASTROENTERITIS 1 0.0017
261 CYTOMEGALOVIRUS TEST POSITIVE 3 0.0017
262 DIAPHRAGMATIC PARALYSIS 1 0.0017
263 NEUTROPHIL COUNT DECREASED 68 0.0017
264 EMBOLISM ARTERIAL 2 0.0017
265 VARICES OESOPHAGEAL 5 0.0017
266 PHARYNGEAL HAEMORRHAGE 2 0.0016
267 ERYTHEMA MULTIFORME 15 0.0016
268 DERMATOSIS 1 0.0016
269 BLOOD OSMOLARITY DECREASED 1 0.0016
270 INTERVERTEBRAL DISCITIS 3 0.0016
271 HYPERTHYROIDISM 23 0.0016
272 TROPONIN T INCREASED 2 0.0016
273 TRANSITIONAL CELL CARCINOMA 2 0.0015
274 CHONDROCALCINOSIS 1 0.0015
275 ACQUIRED GENE MUTATION 2 0.0015
276 METASTASES TO BONE 25 0.0015
277 POLYARTHRITIS 8 0.0015
278 SUDDEN DEATH 16 0.0015
279 PERFORMANCE STATUS DECREASED 7 0.0015
280 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 2 0.0015
281 METASTASES TO CENTRAL NERVOUS SYSTEM 19 0.0015
282 CHOLANGITIS SCLEROSING 3 0.0015
283 RENAL MASS 3 0.0015
284 GRAVITATIONAL OEDEMA 1 0.0014
285 CRANIAL NERVE DISORDER 1 0.0014
286 UPPER GASTROINTESTINAL HAEMORRHAGE 24 0.0014
287 MYELITIS TRANSVERSE 2 0.0014
288 SKIN TOXICITY 8 0.0014
289 SKIN DISORDER 47 0.0014
290 PNEUMATOSIS INTESTINALIS 4 0.0014
291 CRYOGLOBULINAEMIA 1 0.0014
292 CEREBELLAR HAEMORRHAGE 2 0.0014
293 DYSLALIA 1 0.0014
294 GRANULOMA ANNULARE 1 0.0014
295 NORMOCYTIC ANAEMIA 2 0.0014
296 MYASTHENIA GRAVIS CRISIS 2 0.0013
297 BLISTER RUPTURE 1 0.0013
298 MENINGITIS 9 0.0013
299 ATRIOVENTRICULAR BLOCK COMPLETE 9 0.0013
300 CHOLANGIOCARCINOMA 2 0.0013
301 HICCUPS 11 0.0013
302 CREATININE RENAL CLEARANCE INCREASED 1 0.0013
303 INTESTINAL PERFORATION 15 0.0013
304 STEROID DIABETES 2 0.0013
305 FEBRILE NEUTROPENIA 87 0.0013
306 DIAPHRAGMATIC DISORDER 1 0.0013
307 SMALL INTESTINAL OBSTRUCTION 16 0.0013
308 CHONDROCALCINOSIS PYROPHOSPHATE 1 0.0013
309 HEPATIC FAILURE 39 0.0013
310 INFUSION SITE INFECTION 3 0.0013
311 ENDOCARDITIS BACTERIAL 1 0.0013
312 BRONCHIAL CARCINOMA 1 0.0013
313 BLOOD FIBRINOGEN INCREASED 1 0.0013
314 CARDIAC TAMPONADE 6 0.0013
315 EROSIVE DUODENITIS 1 0.0013
316 TUMOUR MARKER INCREASED 6 0.0012
317 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2 0.0012
318 SCLERITIS 2 0.0012
319 CHRONIC HEPATITIS 1 0.0012
320 GIANT CELL ARTERITIS 1 0.0012
321 STRESS CARDIOMYOPATHY 7 0.0012
322 PNEUMONIA BACTERIAL 11 0.0012
323 MYOCARDIAL NECROSIS MARKER INCREASED 2 0.0012
324 METASTASES TO PERITONEUM 3 0.0012
325 METASTASES TO LYMPH NODES 8 0.0012
326 WOUND DEHISCENCE 4 0.0012
327 NEOPLASM RECURRENCE 4 0.0012
328 ABDOMINAL INFECTION 3 0.0012
329 TUBULOINTERSTITIAL NEPHRITIS 22 0.0012
330 CANCER PAIN 3 0.0012
331 AUTOIMMUNE HAEMOLYTIC ANAEMIA 4 0.0012
332 HEPATIC HAEMORRHAGE 1 0.0012
333 MULTIPLE ORGAN DYSFUNCTION SYNDROME 33 0.0012
334 APLASIA PURE RED CELL 4 0.0012
335 ASCITES 34 0.0012
336 ABDOMINAL SEPSIS 1 0.0011
337 NECROTISING FASCIITIS 4 0.0011
338 CARDIAC OUTPUT DECREASED 1 0.0011
339 GASTROINTESTINAL OEDEMA 2 0.0011
340 CANDIDA SEPSIS 1 0.0011
341 PROTEINURIA 21 0.0011
342 DERMATITIS 23 0.0011
343 CUTANEOUS VASCULITIS 4 0.0011
344 PNEUMOCYSTIS JIROVECII PNEUMONIA 11 0.0011
345 ANEURYSM RUPTURED 1 0.0011
346 PERICARDIAL EFFUSION 25 0.0011
347 DRUG ERUPTION 19 0.0011
348 LIVER FUNCTION TEST INCREASED 23 0.0011
349 APPENDICITIS 10 0.0011
350 HAEMORRHAGIC ARTERIOVENOUS MALFORMATION 1 0.0011
351 PEMPHIGOID 8 0.0011
352 CHOLECYSTITIS ACUTE 6 0.0011
353 PANCREATIC CARCINOMA METASTATIC 3 0.0011
354 TROPONIN INCREASED 8 0.0011
355 CEREBELLAR ATAXIA 1 0.0010
356 RASH MACULO-PAPULAR 23 0.0010
357 OPTIC ISCHAEMIC NEUROPATHY 4 0.0010
358 TUMOUR LYSIS SYNDROME 9 0.0010
359 BICYTOPENIA 2 0.0010
360 DUODENAL PERFORATION 1 0.0010
361 DEVICE RELATED THROMBOSIS 1 0.0010
362 CELL DEATH 2 0.0010
363 CARDIAC ANEURYSM 1 0.0010
364 BLOOD DISORDER 8 0.0010
365 TRANSAMINASES INCREASED 22 0.0010
366 DERMATITIS PSORIASIFORM 2 0.0010
367 LARYNGEAL OEDEMA 6 0.0010
368 DIVERTICULAR PERFORATION 2 0.0010
369 CEREBRAL ISCHAEMIA 5 0.0010
370 ILEUS 12 0.0010
371 BLOOD BILIRUBIN INCREASED 26 0.0010
372 HEPATIC CIRRHOSIS 18 0.0010
373 LOWER GASTROINTESTINAL HAEMORRHAGE 7 0.0009
374 BILE DUCT STONE 3 0.0009
375 CLOSTRIDIUM DIFFICILE COLITIS 10 0.0009
376 BLOOD SODIUM ABNORMAL 1 0.0009
377 BACTERIAL SEPSIS 3 0.0009
378 HAEMORRHAGIC DISORDER 1 0.0009
379 HENOCH-SCHONLEIN PURPURA 2 0.0009
380 CARDIAC AMYLOIDOSIS 1 0.0009
381 THYROID DISORDER 14 0.0009
382 CLOSTRIDIUM TEST POSITIVE 2 0.0009
383 PRESYNCOPE 22 0.0009
384 ASPARTATE AMINOTRANSFERASE INCREASED 48 0.0009
385 PARESIS 2 0.0009
386 ILEUS PARALYTIC 4 0.0009
387 METASTASES TO SPINE 3 0.0009
388 SKIN INFECTION 10 0.0009
389 GASTROINTESTINAL ULCER HAEMORRHAGE 1 0.0009
390 DIVERTICULUM INTESTINAL HAEMORRHAGIC 2 0.0009
391 MYELOSUPPRESSION 32 0.0009
392 CARDIOMYOPATHY 13 0.0009
393 ATRIAL FLUTTER 7 0.0009
394 ARTERIAL HAEMORRHAGE 1 0.0009
395 NEPHROTIC SYNDROME 6 0.0009
396 PANCREATITIS 46 0.0009
397 CYTOMEGALOVIRUS COLITIS 2 0.0009
398 LOCALISED OEDEMA 4 0.0009
399 NEUROLOGICAL DECOMPENSATION 2 0.0009
400 METHAEMOGLOBINAEMIA 2 0.0009
401 HAEMOLYTIC URAEMIC SYNDROME 2 0.0009
402 EPIDIDYMITIS 1 0.0009
403 METASTASES TO LIVER 15 0.0009
404 GLOMERULONEPHRITIS MEMBRANOUS 1 0.0009
405 FEBRILE INFECTION 1 0.0008
406 COLITIS MICROSCOPIC 4 0.0008
407 HORMONE-REFRACTORY PROSTATE CANCER 1 0.0008
408 CARDIAC DEATH 1 0.0008
409 CEREBRAL ARTERY EMBOLISM 1 0.0008
410 GLOMERULONEPHRITIS 2 0.0008
411 PLATELET COUNT DECREASED 87 0.0008
412 ENCEPHALOPATHY 20 0.0008
413 HYPOPHOSPHATAEMIA 6 0.0008
414 STEVENS-JOHNSON SYNDROME 18 0.0008
415 SEPSIS 90 0.0008
416 AMPUTATION 1 0.0008
417 SYSTEMIC CANDIDA 2 0.0008
418 GASTRIC ULCER PERFORATION 1 0.0008
419 PLEURAL EFFUSION 48 0.0008
420 EYELID PTOSIS 8 0.0008
421 DISSEMINATED INTRAVASCULAR COAGULATION 11 0.0008
422 JAUNDICE 21 0.0008
423 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 8 0.0008
424 CEREBRAL INFARCTION 19 0.0008
425 PERICARDITIS 13 0.0008
426 APLASTIC ANAEMIA 4 0.0008
427 EXTRADURAL HAEMATOMA 1 0.0008
428 COMPRESSION FRACTURE 4 0.0007
429 HAEMATOTOXICITY 7 0.0007
430 CYTOPENIA 9 0.0007
431 GASTRIC PERFORATION 2 0.0007
432 RENAL DISORDER 34 0.0007
433 BLOOD CREATINE PHOSPHOKINASE INCREASED 21 0.0007
434 BILIARY TRACT DISORDER 1 0.0007
435 DIABETIC METABOLIC DECOMPENSATION 1 0.0007
436 ALANINE AMINOTRANSFERASE INCREASED 44 0.0007
437 PROCTITIS 2 0.0007
438 HYPERGLYCAEMIA 26 0.0007
439 ALVEOLITIS 1 0.0007
440 CARDIAC FAILURE CHRONIC 3 0.0007
441 OESOPHAGEAL STENOSIS 2 0.0007
442 CHORIORETINOPATHY 1 0.0007
443 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
444 METASTATIC NEOPLASM 3 0.0007
445 PNEUMOTHORAX 11 0.0007
446 ALTERED STATE OF CONSCIOUSNESS 15 0.0007
447 MONOPLEGIA 3 0.0007
448 FOOT AMPUTATION 1 0.0007
449 VASCULITIS 8 0.0007
450 GASTROINTESTINAL NECROSIS 2 0.0007
451 GASTROENTERITIS 10 0.0007
452 URINE ODOUR ABNORMAL 4 0.0007
453 ENTEROCOLITIS HAEMORRHAGIC 1 0.0007
454 CHOLECYSTITIS 8 0.0007
455 PHOTOSENSITIVITY REACTION 11 0.0007
456 PAPILLOEDEMA 3 0.0007
457 BLOOD THYROID STIMULATING HORMONE DECREASED 3 0.0007
458 THROMBOPHLEBITIS SUPERFICIAL 2 0.0007
459 PYREXIA 228 0.0007
460 GASTRITIS EROSIVE 3 0.0006
461 PNEUMONIA ASPIRATION 16 0.0006
462 PULMONARY HAEMORRHAGE 5 0.0006
463 HEPATITIS E 1 0.0006
464 HEPATOTOXICITY 14 0.0006
465 ORTHOPNOEA 2 0.0006
466 EOSINOPHILIA 11 0.0006
467 GASTROINTESTINAL TOXICITY 3 0.0006
468 DIABETIC KETOACIDOSIS 15 0.0006
469 ACUTE RESPIRATORY DISTRESS SYNDROME 11 0.0006
470 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 16 0.0006
471 ATELECTASIS 6 0.0006
472 AORTIC VALVE DISEASE 1 0.0006
473 SEPTIC SHOCK 27 0.0006
474 THROMBOTIC MICROANGIOPATHY 6 0.0006
475 HEPATITIS ACUTE 4 0.0006
476 BRADYARRHYTHMIA 1 0.0006
477 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 2 0.0006
478 HYPONATRAEMIA 34 0.0006
479 CARDIAC FAILURE ACUTE 4 0.0006
480 CORONARY ARTERY STENOSIS 3 0.0006
481 BACTERAEMIA 7 0.0006
482 FACIAL PARALYSIS 5 0.0006
483 SKIN ULCER 15 0.0006
484 AMYLOIDOSIS 1 0.0006
485 C-REACTIVE PROTEIN INCREASED 21 0.0006
486 DERMATITIS EXFOLIATIVE GENERALISED 2 0.0006
487 EXTREMITY NECROSIS 1 0.0006
488 GASTRITIS 15 0.0006
489 SERUM FERRITIN INCREASED 3 0.0006
490 EMBOLIC STROKE 2 0.0006
491 HAEMORRHAGE SUBCUTANEOUS 2 0.0006
492 NEUTROPENIC SEPSIS 4 0.0006
493 DRUG MONITORING PROCEDURE NOT PERFORMED 1 0.0006
494 DEHYDRATION 74 0.0006
495 BLOOD PHOSPHORUS DECREASED 2 0.0005
496 CONTRAST MEDIA ALLERGY 1 0.0005
497 GASTROINTESTINAL PAIN 6 0.0005
498 INTESTINAL ISCHAEMIA 3 0.0005
499 GAMMA-GLUTAMYLTRANSFERASE INCREASED 12 0.0005
500 AGRANULOCYTOSIS 10 0.0005
501 NEPHROPATHY TOXIC 6 0.0005
502 KETOACIDOSIS 4 0.0005
503 PANCREATITIS ACUTE 12 0.0005
504 THROMBOCYTOPENIA 59 0.0005
505 TOXIC EPIDERMAL NECROLYSIS 8 0.0005
506 ARTERIAL DISORDER 1 0.0005
507 ACIDOSIS 4 0.0005
508 GASTRIC HAEMORRHAGE 6 0.0005
509 CUTANEOUS LUPUS ERYTHEMATOSUS 1 0.0005
510 PERIPHERAL SENSORY NEUROPATHY 3 0.0005
511 AUTOIMMUNE DISORDER 5 0.0005
512 GASTROINTESTINAL INFLAMMATION 4 0.0005
513 VENOUS THROMBOSIS 2 0.0005
514 GENE MUTATION 1 0.0005
515 PLEURISY 3 0.0005
516 RENAL CYST 4 0.0005
517 EMPYEMA 1 0.0005
518 ARTERIOSPASM CORONARY 2 0.0005
519 HEPATITIS B 3 0.0005
520 DERMATITIS ACNEIFORM 3 0.0005
521 EYELID PAIN 1 0.0005
522 RECURRENT CANCER 2 0.0005
523 ACUTE KIDNEY INJURY 75 0.0005
524 DEMYELINATION 2 0.0005
525 ARTHRITIS BACTERIAL 2 0.0005
526 HYPERCALCAEMIA 6 0.0005
527 PIGMENTATION DISORDER 3 0.0005
528 EOSINOPHIL COUNT INCREASED 4 0.0005
529 DEATH 412 0.0005
530 DILATATION VENTRICULAR 1 0.0005
531 HEPATIC CYTOLYSIS 6 0.0005
532 CATHETER SITE ERYTHEMA 1 0.0005
533 DIARRHOEA 301 0.0005
534 HAEMOPTYSIS 13 0.0005
535 RENAL IMPAIRMENT 39 0.0005
536 MYOPATHY 4 0.0005
537 PYELONEPHRITIS 4 0.0005
538 HEPATIC CANCER 11 0.0005
539 ADENOCARCINOMA 1 0.0004
540 FEEDING DISORDER 9 0.0004
541 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
542 CHRONIC GASTRITIS 1 0.0004
543 BLOOD LOSS ANAEMIA 1 0.0004
544 ANAEMIA 84 0.0004
545 BLOOD THYROID STIMULATING HORMONE INCREASED 4 0.0004
546 EYELID DISORDER 1 0.0004
547 NEPHROGENIC ANAEMIA 2 0.0004
548 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 1 0.0004
549 HYPERKALAEMIA 15 0.0004
550 ESCHERICHIA BACTERAEMIA 1 0.0004
551 COLORECTAL CANCER METASTATIC 1 0.0004
552 CYTOMEGALOVIRUS INFECTION 7 0.0004
553 SARCOIDOSIS 2 0.0004
554 POLYNEUROPATHY 5 0.0004
555 HYPOVOLAEMIC SHOCK 2 0.0004
556 DIABETES INSIPIDUS 1 0.0004
557 PANCYTOPENIA 23 0.0004
558 RESPIRATORY FAILURE 30 0.0004
559 PANCREATIC DISORDER 2 0.0004
560 ACUTE PSYCHOSIS 1 0.0004
561 BRAIN OEDEMA 5 0.0004
562 DERMATOMYOSITIS 1 0.0004
563 ANGLE CLOSURE GLAUCOMA 1 0.0004
564 DECREASED APPETITE 91 0.0004
565 LUNG DISORDER 19 0.0004
566 DRUG TITRATION ERROR 1 0.0004
567 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 9 0.0004
568 HEPATITIS TOXIC 1 0.0004
569 PNEUMONIA 124 0.0004
570 ARTHRITIS 30 0.0004
571 DISEASE PROGRESSION 45 0.0004
572 BLOOD ALBUMIN DECREASED 3 0.0004
573 BLOOD POTASSIUM ABNORMAL 1 0.0004
574 NEOPLASM PROGRESSION 13 0.0004
575 ABDOMINAL MASS 1 0.0004
576 ACUTE MYOCARDIAL INFARCTION 11 0.0004
577 OEDEMA 20 0.0004
578 UVEITIS 5 0.0004
579 LIVER INJURY 9 0.0004
580 ACUTE HEPATIC FAILURE 5 0.0004
581 ACUTE RESPIRATORY FAILURE 7 0.0004
582 DEAFNESS UNILATERAL 2 0.0004
583 INFUSION RELATED REACTION 24 0.0004
584 GASTRIC ULCER HAEMORRHAGE 2 0.0004
585 LEUKOPENIA 18 0.0004
586 ANURIA 3 0.0003
587 CARDIOGENIC SHOCK 5 0.0003
588 HERPES VIRUS INFECTION 2 0.0003
589 MOUTH SWELLING 2 0.0003
590 RASH 151 0.0003
591 TASTE DISORDER 7 0.0003
592 HAEMOTHORAX 1 0.0003
593 HEPATITIS FULMINANT 1 0.0003
594 CARDIOTOXICITY 3 0.0003
595 HAEMOLYTIC ANAEMIA 3 0.0003
596 BRAIN HERNIATION 1 0.0003
597 ENDOPHTHALMITIS 2 0.0003
598 HYPERCAPNIA 1 0.0003
599 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
600 UROSEPSIS 3 0.0003
601 FIBROSIS 1 0.0003
602 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
603 CARDIAC FAILURE 26 0.0003
604 THERAPY PARTIAL RESPONDER 5 0.0003
605 EOSINOPHILIC PNEUMONIA 1 0.0003
606 FAECAL CALPROTECTIN INCREASED 1 0.0003
607 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0003
608 ABDOMINAL PAIN 73 0.0003
609 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
610 CHOLESTASIS 6 0.0003
611 HYPOXIA 11 0.0003
612 RHABDOMYOLYSIS 13 0.0003
613 HERPES SIMPLEX 2 0.0003
614 HEPATIC NEOPLASM 1 0.0003
615 POLYP 2 0.0003
616 DIABETES MELLITUS 23 0.0003
617 HEPATIC CYST 1 0.0003
618 NEUTROPHIL COUNT INCREASED 3 0.0003
619 EYE MOVEMENT DISORDER 2 0.0003
620 MUSCULAR WEAKNESS 33 0.0003
621 HYPERBILIRUBINAEMIA 3 0.0003
622 BLOOD CREATININE ABNORMAL 1 0.0003
623 DELIRIUM 10 0.0003
624 ORTHOSTATIC HYPOTENSION 5 0.0003
625 FACIAL PARESIS 1 0.0003
626 HYPOKALAEMIA 13 0.0003
627 METABOLIC ACIDOSIS 9 0.0003
628 UPPER RESPIRATORY TRACT INFECTION 13 0.0003
629 METASTASIS 2 0.0003
630 DERMATITIS BULLOUS 2 0.0003
631 WOUND INFECTION 3 0.0003
632 MOUTH HAEMORRHAGE 2 0.0003
633 ANAPHYLACTIC SHOCK 7 0.0003
634 ANAPHYLACTIC REACTION 15 0.0003
635 HEPATIC CANCER STAGE IV 1 0.0003
636 DIPLOPIA 7 0.0003
637 CARDIAC DYSFUNCTION 1 0.0003
638 COLON CANCER 4 0.0003
639 ECZEMA 14 0.0003
640 HAEMORRHAGE INTRACRANIAL 4 0.0003
641 REBOUND EFFECT 3 0.0003
642 PAROSMIA 2 0.0003
643 HYPOCALCAEMIA 5 0.0003
644 FRACTURE 5 0.0003
645 GASTROINTESTINAL HAEMORRHAGE 22 0.0003
646 GASTRIC ULCER 5 0.0003
647 BOWEL MOVEMENT IRREGULARITY 2 0.0003
648 NEOPLASM 3 0.0003
649 SHOCK 6 0.0003
650 DEVICE RELATED INFECTION 4 0.0003
651 GENERAL PHYSICAL HEALTH DETERIORATION 30 0.0003
652 ATRIOVENTRICULAR BLOCK 2 0.0003
653 NEUTROPENIA 35 0.0003
654 HYPOALBUMINAEMIA 2 0.0003
655 RENAL FAILURE 34 0.0003
656 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
657 COVID-19 PNEUMONIA 3 0.0003
658 AZOTAEMIA 1 0.0003
659 BLEPHARITIS 1 0.0002
660 WHITE BLOOD CELL COUNT DECREASED 27 0.0002
661 CYSTITIS HAEMORRHAGIC 1 0.0002
662 CHILLS 29 0.0002
663 MUSCLE DISORDER 2 0.0002
664 SHOCK HAEMORRHAGIC 2 0.0002
665 ASPHYXIA 2 0.0002
666 EXTRAVASATION 1 0.0002
667 ESCHERICHIA INFECTION 2 0.0002
668 ANAPHYLACTOID REACTION 1 0.0002
669 VENTRICULAR TACHYCARDIA 4 0.0002
670 ACUTE CORONARY SYNDROME 2 0.0002
671 HEMIPLEGIA 2 0.0002
672 CANDIDA INFECTION 4 0.0002
673 HEPATIC PAIN 1 0.0002
674 HEPATIC LESION 1 0.0002
675 MUCOSAL INFLAMMATION 6 0.0002
676 URINE OUTPUT DECREASED 2 0.0002
677 DIVERTICULUM INTESTINAL 1 0.0002
678 IMMUNE SYSTEM DISORDER 3 0.0002
679 LUNG INFILTRATION 2 0.0002
680 OROPHARYNGEAL DISCOMFORT 2 0.0002
681 NEUROPATHY PERIPHERAL 21 0.0002
682 DISEASE COMPLICATION 1 0.0002
683 MOVEMENT DISORDER 7 0.0002
684 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
685 CHRONIC MYELOID LEUKAEMIA 1 0.0002
686 ARTHRITIS INFECTIVE 1 0.0002
687 HYPOMAGNESAEMIA 3 0.0002
688 COORDINATION ABNORMAL 3 0.0002
689 HEPATIC STEATOSIS 4 0.0002
690 STOMATITIS 13 0.0002
691 SKIN REACTION 3 0.0002
692 LEUKAEMIA 2 0.0002
693 HEPATOCELLULAR INJURY 3 0.0002
694 AFFECT LABILITY 2 0.0002
695 PANCREATIC CARCINOMA 6 0.0002
696 HUMERUS FRACTURE 1 0.0002
697 HEPATOMEGALY 2 0.0002
698 HEPARIN-INDUCED THROMBOCYTOPENIA 1 0.0002
699 COLITIS ULCERATIVE 9 0.0002
700 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
701 HYPERNATRAEMIA 1 0.0002
702 HEPATIC ENZYME ABNORMAL 1 0.0002
703 FLUID INTAKE REDUCED 1 0.0002
704 TOXIC SKIN ERUPTION 2 0.0002
705 EMPHYSEMA 2 0.0002
706 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
707 OEDEMA PERIPHERAL 24 0.0002
708 DYSLIPIDAEMIA 1 0.0002
709 BLOOD PRESSURE DECREASED 13 0.0002
710 CEREBRAL HAEMORRHAGE 7 0.0002
711 DRUG RESISTANCE 5 0.0002
712 CACHEXIA 1 0.0002
713 PERITONITIS 4 0.0002
714 RESPIRATORY TRACT INFECTION 5 0.0002
715 HEPATIC ENZYME INCREASED 13 0.0002
716 ARRHYTHMIA 9 0.0002
717 PULMONARY EMBOLISM 18 0.0002
718 PRURITUS 72 0.0002
719 VOMITING 88 0.0002
720 ANAL FISSURE 1 0.0002
721 ANAL ABSCESS 1 0.0002
722 ATRIAL FIBRILLATION 18 0.0002
723 FAECES DISCOLOURED 4 0.0002
724 HYPOTENSION 37 0.0002
725 OESOPHAGITIS 2 0.0002
726 ASPIRATION 2 0.0002
727 COVID-19 32 0.0002
728 HAEMATOCHEZIA 10 0.0002
729 MENTAL STATUS CHANGES 5 0.0002
730 SNEEZING 4 0.0002
731 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
732 INFLAMMATION 9 0.0002
733 ELECTROLYTE IMBALANCE 2 0.0002
734 MALAISE 75 0.0002
735 SPLENOMEGALY 2 0.0002
736 LYMPHADENOPATHY 6 0.0002
737 ISCHAEMIC STROKE 3 0.0002
738 HEPATITIS CHOLESTATIC 1 0.0002
739 LEUKOCYTOSIS 3 0.0002
740 EPILEPSY 5 0.0002
741 PHARYNGITIS 2 0.0002
742 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
743 BLEPHAROSPASM 1 0.0002
744 CELLULITIS 8 0.0002
745 MUSCLE ATROPHY 2 0.0002
746 HYPOPHAGIA 4 0.0002
747 CONFUSIONAL STATE 25 0.0002
748 ANGINA UNSTABLE 1 0.0002
749 CEREBROVASCULAR ACCIDENT 26 0.0002
750 URINARY TRACT INFECTION 26 0.0002
751 PULMONARY CONGESTION 2 0.0002
752 ADVERSE REACTION 2 0.0002
753 QUALITY OF LIFE DECREASED 2 0.0001
754 COLITIS ISCHAEMIC 1 0.0001
755 RASH PRURITIC 8 0.0001
756 GINGIVAL BLEEDING 2 0.0001
757 RASH ERYTHEMATOUS 7 0.0001
758 BLOOD TESTOSTERONE DECREASED 1 0.0001
759 HAEMATURIA 5 0.0001
760 INFECTION 21 0.0001
761 PULMONARY HYPERTENSION 3 0.0001
762 CARDIO-RESPIRATORY ARREST 6 0.0001
763 OXYGEN SATURATION DECREASED 8 0.0001
764 DEVICE OCCLUSION 2 0.0001
765 DUODENAL ULCER 1 0.0001
766 LYMPHOPENIA 2 0.0001
767 BRONCHOSPASM 2 0.0001
768 SUBDURAL HAEMATOMA 2 0.0001
769 PARALYSIS 2 0.0001
770 DEEP VEIN THROMBOSIS 9 0.0001
771 MYELODYSPLASTIC SYNDROME 2 0.0001
772 BLOOD CREATININE INCREASED 9 0.0001
773 CONSTIPATION 30 0.0001
774 FAECES SOFT 1 0.0001
775 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
776 RESPIRATORY DISORDER 4 0.0001
777 GENERAL SYMPTOM 1 0.0001
778 CARDIAC ARREST 11 0.0001
779 INTESTINAL OBSTRUCTION 5 0.0001
780 HAEMOLYSIS 1 0.0001
781 MUSCULOSKELETAL CHEST PAIN 2 0.0001
782 FEMUR FRACTURE 4 0.0001
783 LUNG INFECTION 2 0.0001
784 EJECTION FRACTION DECREASED 2 0.0001
785 APNOEA 1 0.0001
786 BASAL CELL CARCINOMA 2 0.0001
787 NERVOUS SYSTEM DISORDER 4 0.0001
788 HAEMORRHAGIC STROKE 1 0.0001
789 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
790 GINGIVAL PAIN 1 0.0001
791 PSORIATIC ARTHROPATHY 5 0.0001
792 GASTROINTESTINAL DISORDER 11 0.0001
793 HYPERTENSION 26 0.0001
794 HERPES ZOSTER 7 0.0001
795 DYSPNOEA 68 0.0001
796 COAGULOPATHY 2 0.0001
797 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
798 TYPE 2 DIABETES MELLITUS 4 0.0001
799 HAEMATEMESIS 3 0.0001
800 CARDIAC MURMUR 1 0.0001
801 DEAFNESS 3 0.0001
802 RHEUMATOID ARTHRITIS 13 0.0001
803 BLOOD CALCIUM INCREASED 1 0.0001
804 TACHYCARDIA 10 0.0001
805 GOUT 2 0.0001
806 ANAL INCONTINENCE 1 0.0001
807 SYNCOPE 11 0.0001
808 HIDRADENITIS 1 0.0001
809 BRAIN NEOPLASM 1 0.0001
810 TINNITUS 5 0.0001
811 BACTERIAL INFECTION 2 0.0001
812 HAEMOGLOBIN DECREASED 11 0.0001
813 FLANK PAIN 1 0.0001
814 ARTERIOSCLEROSIS 1 0.0001
815 LETHARGY 6 0.0001
816 PULMONARY FIBROSIS 2 0.0001
817 NAUSEA 82 0.0001
818 DIZZINESS POSTURAL 1 0.0001
819 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
820 COELIAC DISEASE 1 0.0001
821 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
822 LOSS OF CONSCIOUSNESS 13 0.0001
823 SPINAL FRACTURE 2 0.0001
824 OFF LABEL USE 87 0.0001
825 MYOCARDIAL INFARCTION 17 0.0001
826 LUNG NEOPLASM MALIGNANT 4 0.0001
827 HELICOBACTER INFECTION 1 0.0001
828 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
829 TOXICITY TO VARIOUS AGENTS 16 0.0001
830 DYSPHAGIA 9 0.0001
831 RECTAL HAEMORRHAGE 4 0.0001
832 NIGHT SWEATS 3 0.0001
833 DECREASED ACTIVITY 1 0.0001
834 MELAENA 2 0.0001
835 MEDICATION ERROR 5 0.0001
836 URINARY RETENTION 3 0.0001
837 URTICARIA 15 0.0001
838 PULMONARY OEDEMA 4 0.0001
839 ORAL PAIN 2 0.0001
840 BLISTER 5 0.0001
841 CHROMATURIA 2 0.0001
842 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
843 ADVERSE EVENT 8 0.0001
844 BACK PAIN 20 0.0001
845 DYSPHONIA 5 0.0001
846 ASTHENIA 32 0.0001
847 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
848 PSORIASIS 11 0.0001
849 PRODUCTIVE COUGH 4 0.0001
850 FATIGUE 65 0.0001
851 HEPATITIS C 1 0.0001
852 BURSITIS 1 0.0001
853 MYALGIA 14 0.0001
854 RESTLESSNESS 3 0.0001
855 CARDIOMEGALY 1 0.0001
856 CYST 1 0.0001
857 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
858 DYSPNOEA EXERTIONAL 3 0.0001
859 CHRONIC KIDNEY DISEASE 6 0.0001
860 CARDIOVASCULAR DISORDER 2 0.0001
861 GAIT DISTURBANCE 15 0.0001
862 HIATUS HERNIA 1 0.0001
863 ANKYLOSING SPONDYLITIS 1 0.0001
864 BRADYCARDIA 4 0.0001
865 WEIGHT DECREASED 21 0.0001
866 NEOPLASM MALIGNANT 5 0.0001
867 CARDIAC DISORDER 7 0.0001
868 THROMBOSIS 6 0.0001
869 DRY MOUTH 6 0.0001
870 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
871 RESPIRATORY ARREST 2 0.0001
872 RESPIRATORY DISTRESS 2 0.0001
873 DIVERTICULITIS 2 0.0001
874 NO ADVERSE EVENT 13 0.0001
875 APHONIA 1 0.0001
876 BLOOD TEST ABNORMAL 1 0.0001
877 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
878 ANGINA PECTORIS 2 0.0001
879 HYPERSOMNIA 2 0.0001
880 SEIZURE 8 0.0001
881 LIVER FUNCTION TEST ABNORMAL 2 0.0001
882 DYSSTASIA 2 0.0001
883 ABDOMINAL DISTENSION 7 0.0001
884 HALLUCINATION 5 0.0001
885 COGNITIVE DISORDER 3 0.0001
886 ACUTE MYELOID LEUKAEMIA 1 0.0001
887 CARDIAC FAILURE CONGESTIVE 5 0.0001
888 BLOOD POTASSIUM INCREASED 1 0.0001
889 FUNGAL INFECTION 2 0.0001
890 GAIT INABILITY 2 0.0001
891 FACE OEDEMA 1 0.0001
892 FLUID RETENTION 3 0.0001
893 CIRCULATORY COLLAPSE 1 0.0001
894 ARTHRALGIA 24 0.0001
895 HAEMORRHAGE 6 0.0001
896 RASH MACULAR 2 0.0001
897 FALL 19 0.0001
898 MOBILITY DECREASED 4 0.0001
899 DYSURIA 2 0.0001
900 BLOOD GLUCOSE ABNORMAL 1 0.0001
901 CONJUNCTIVITIS 1 0.0001
902 HYPERSENSITIVITY 10 0.0001
903 NECK PAIN 3 0.0001
904 EPISTAXIS 4 0.0001
905 FLATULENCE 3 0.0001
906 HOSPITALISATION 8 0.0001
907 HAEMORRHOIDS 1 0.0001
908 BONE PAIN 3 0.0001
909 DISORIENTATION 2 0.0001
910 HAEMATOCRIT DECREASED 1 0.0001
911 COUGH 14 0.0000
912 FULL BLOOD COUNT DECREASED 1 0.0000
913 VERTIGO 3 0.0000
914 BONE MARROW FAILURE 1 0.0000
915 BODY TEMPERATURE INCREASED 1 0.0000
916 ERYTHEMA 10 0.0000
917 CHEST PAIN 9 0.0000
918 VAGINAL HAEMORRHAGE 2 0.0000
919 ALOPECIA 9 0.0000
920 HEART RATE IRREGULAR 1 0.0000
921 COMA 2 0.0000
922 SOMNOLENCE 8 0.0000
923 ABDOMINAL PAIN LOWER 1 0.0000
924 ABDOMINAL PAIN UPPER 8 0.0000
925 ILLNESS 4 0.0000
926 HAEMATOMA 1 0.0000
927 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
928 DISTURBANCE IN ATTENTION 2 0.0000
929 FREQUENT BOWEL MOVEMENTS 1 0.0000
930 INFLUENZA LIKE ILLNESS 3 0.0000
931 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
932 FEELING COLD 1 0.0000
933 DEMENTIA 1 0.0000
934 PAIN 21 0.0000
935 INSOMNIA 9 0.0000
936 ADVERSE DRUG REACTION 3 0.0000
937 BLOOD POTASSIUM DECREASED 1 0.0000
938 APHASIA 1 0.0000
939 CORONARY ARTERY DISEASE 1 0.0000
940 ILL-DEFINED DISORDER 2 0.0000
941 DISCOMFORT 2 0.0000
942 PERIPHERAL SWELLING 5 0.0000
943 PRODUCT USE ISSUE 6 0.0000
944 HEADACHE 20 0.0000
945 CYSTITIS 1 0.0000
946 HYPERHIDROSIS 4 0.0000
947 RHINORRHOEA 2 0.0000
948 EYE DISORDER 1 0.0000
949 HEART RATE INCREASED 3 0.0000
950 TREMOR 5 0.0000
951 EYE PRURITUS 1 0.0000
952 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
953 THERAPY INTERRUPTED 2 0.0000
954 BRONCHITIS 2 0.0000
955 DYSGEUSIA 2 0.0000
956 HYPOAESTHESIA 4 0.0000
957 ASTHMA 3 0.0000
958 CONDITION AGGRAVATED 8 0.0000
959 DIZZINESS 13 0.0000
960 ABNORMAL BEHAVIOUR 1 0.0000
961 DYSKINESIA 1 0.0000
962 BLINDNESS 1 0.0000
963 SUICIDAL IDEATION 2 0.0000
964 MUSCLE SPASMS 4 0.0000
965 DISEASE RECURRENCE 1 0.0000
966 BLOOD GLUCOSE DECREASED 1 0.0000
967 DRUG INTOLERANCE 2 0.0000
968 DYSPEPSIA 2 0.0000
969 DRUG INEFFECTIVE 26 0.0000
970 FLUSHING 2 0.0000
971 BLOOD PRESSURE INCREASED 3 0.0000
972 CHEST DISCOMFORT 2 0.0000
973 SINUSITIS 2 0.0000
974 PARAESTHESIA 3 0.0000
975 DERMATITIS ATOPIC 1 0.0000
976 OVERDOSE 4 0.0000
977 WEIGHT INCREASED 4 0.0000
978 CATARACT 1 0.0000
979 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
980 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
981 BLOOD GLUCOSE INCREASED 3 0.0000
982 VISION BLURRED 2 0.0000
983 MEMORY IMPAIRMENT 2 0.0000
984 ANXIETY 4 0.0000
985 AGITATION 1 0.0000
986 DEPRESSION 3 0.0000
987 DRUG INTERACTION 2 0.0000
988 FEELING ABNORMAL 3 0.0000
989 ABDOMINAL DISCOMFORT 2 0.0000
990 DRY SKIN 1 0.0000
991 PRODUCT DOSE OMISSION ISSUE 2 0.0000
992 PAIN IN EXTREMITY 2 0.0000